NIH turns to crowdsourcing to repurpose drugs

Initial success exceeds expectations

2014-07-16

(Press-News.org) New Rochelle, NY, July 16, 2014–Experimental drugs proven safe but perhaps not sufficiently effective in initial testing or against a first disease target may sit gathering dust on the shelves of pharmaceutical companies. An NIH-sponsored effort based on a crowdsourcing strategy to establish collaborations between industrial and academic partners to test and develop these therapeutic compounds was met with an overwhelming response and has led to clinical testing of a broad range of pilot projects and a newly announced round of funding opportunities. These findings are described in a Review article in the preview issue of the new journal Drug Repurposing, Rescue, and Repositioning, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Drug Repurposing, Rescue, and Repositioning website.

Christine M. Colvis, PhD and Christopher P. Austin, MD, National Center for Advancing Translational Sciences, National Institutes of Health (NIH), Bethesda, MD, explain that the Center does not focus on a particular disease or organ system, allowing it to support a broad scope of projects that link indications with unmet medical needs to the mechanisms of action of new drug compounds that are ready to move into patient testing. In the article "The NIH-Industry New Therapeutic Uses Pilot Program: Demonstrating the Power of Crowdsourcing") the authors state that among the new funding opportunity announcements released by the Center in May were 12 therapeutic agents for pediatric indication consideration.

"This article describes not only how targeted crowdsourcing can link up the assets, the know-how, and the creativity that drug repurposing needs, but also how such a program can be organized to serve the best interests of all concerned parties," says journal Editor Hermann Mucke, PhD, H.M. Pharma Consultancy, Vienna, Austria. "Pharmaceutical companies and academia must collaborate to leverage their huge potential synergies in compound re-development, and by arranging and mentoring this pilot program NCATS has firmly established its role as a mediator in drug repurposing."

INFORMATION: About the Journal Drug Repurposing, Rescue, and Repositioning, a dynamic new peer-reviewed journal, presents techniques and tools for finding new uses for approved drugs — particularly for disorders where no animal model, physiologic abnormality, biochemical pathway, or molecular target has been identified. Led by Editor-in-Chief Aris Persidis, Biovista, Inc., and Editor Hermann Mucke, H.M. Pharma Consultancy e.U, the Journal provides a new interdisciplinary platform for scientific contributions to the field of drug repurposing including original research papers, reviews, case studies, application-oriented technology assessments, and reports in methodology and technology application. The Journal is published quarterly online with Open Access options and in print. A sample issue may be viewed on the Drug Repurposing, Rescue, and Repositioning website

About the Publisher Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many areas of science and biomedical research, including ASSAY and Drug Development Technologies, Big Data, and Biotechnology Law Report. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215 Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101 http://www.liebertpub.com Contact: Kathryn Ruehle, Mary Ann Liebert, Inc., (914) 740-2100, kruehle@liebertpub.com

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

What do Google searches tell us about our climate change fears?

2014-07-16

Republicans search the Net for information about the weather, climate change and global warming during extremely hot or cold spells. Democrats Google these terms when they experience changes in the average temperatures. These are some of the surprising findings from a study by Corey Lang of the University of Rhode Island in the US, published in Springer's journal Climatic Change. He tracked how the temperature fluctuations and rainfall that Americans experience daily in their own cities make them scour the Internet in search of information about climate change and global ...

An anti-glare, anti-reflective display for mobile devices?

2014-07-16

If you've ever tried to watch a video on a tablet on a sunny day, you know you have to tilt it at just the right angle to get rid of glare or invest in a special filter. But now scientists are reporting in the journal ACS Applied Materials & Interfaces that they've developed a novel glass surface that reduces both glare and reflection, which continue to plague even the best mobile displays today. Valerio Pruneri and colleagues note that much effort has been poured into anti-reflective and anti-glare technology. In the highly competitive digital age, any bonus feature ...

Fundamental research is paving the way for development of first vaccine for heart disease

2014-07-16

DETROIT — Researchers at Wayne State University have made a fundamental discovery and, in subsequent collaboration with scientists at La Jolla Institute for Allergy and Immunology (LIAI), are one step closer to the goal of developing the world's first T-cell peptide-based vaccine for heart disease — the number one killer in the nation. Atherosclerosis is a chronic inflammatory disease of the arterial walls, which thicken due to accumulation of fatty materials such as cholesterols and triglycerides. Blocking of arteries supplying blood to the heart is the underlying cause ...

Decoding dengue

2014-07-16

Scientists have discovered a new pathway the dengue virus takes to suppress the human immune system. This new knowledge deepens our understanding of the virus and could contribute to the development of more effective therapeutics. For years, the conventional approach to target the dengue virus was through vector control, which was regarded to be the most effective method. This is because the mechanics of the virus have been elusive, which in turn hampered the development of effective treatments and vaccines. Fortunately a new study, published in the prestigious journal ...

Aqueous two-phase systems enable multiplexing of homogeneous immunoassays

2014-07-16

A new protein biomarker test platform developed by researchers at the University of Michigan and Indiana University promises to improve diagnostic testing. The test can accurately and simultaneously measure multiple proteins that indicate the presence of diseases like graft-versus-host disease (bone marrow transplant rejection) in only two hours, no washing steps, and using only a minute volume of blood plasma. A report on this new technology can be found online in the journal TECHNOLOGY. The protein test uses a micropatterning method developed in Shuichi Takayama's Micro/Nano/Molecular ...

Tracking the breakup of Arctic summer sea ice

2014-07-16

As sea ice begins to melt back toward its late September minimum, it is being watched as never before. Scientists have put sensors on and under ice in the Beaufort Sea for an unprecedented campaign to monitor the summer melt. The international effort hopes to figure out the physics of the ice edge in order to better understand and predict open water in Arctic seas. "This has never been done at this level, over such a large area and for such a long period of time," said principal investigator Craig Lee, an oceanographer at the University of Washington's Applied Physics ...

Breast cancer: DMP is largely consistent with guidelines

2014-07-16

On 16 July 2014 the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with breast cancer. The aim of the report is to identify those recommendations from current guidelines of high methodological quality that may be relevant for the planned revision of the disease management programme (DMP). According to the results of the report, there is no compelling need for revision of any part of the DMP. However, IQWiG identified some aspects that ...

Self-assembling nanoparticle could improve MRI scanning for cancer diagnosis

2014-07-16

Scientists have designed a new self-assembling nanoparticle that targets tumours, to help doctors diagnose cancer earlier. The new nanoparticle, developed by researchers at Imperial College London, boosts the effectiveness of Magnetic Resonance Imaging (MRI) scanning by specifically seeking out receptors that are found in cancerous cells. The nanoparticle is coated with a special protein, which looks for specific signals given off by tumours, and when it finds a tumour it begins to interact with the cancerous cells. This interaction strips off the protein coating, ...

Improving tumour radiation therapy: When basic ions break DNA down

2014-07-16

Scientists now have a better understanding of how short DNA strands decompose in microseconds. A European team found new fragmentation pathways that occur universally when DNA strands are exposed to metal ions from a family of alkaline and alkaline earth elements. These ions tend to replace protons in the DNA backbone and at the same time induce a reactive conformation leading more readily to fragmentation. These findings by Andreas Piekarczyk, from the University of Iceland, and colleagues have been published in a study in EPJ D. They could contribute to optimising cancerous ...

Researchers advance understanding in immune response to infectious disease

2014-07-16

University of Leicester researchers have released evidence substantiating an unexpected dual role of an important component of the immune system. Findings by researchers at the University's Department of Infection, Immunity and Inflammation – including three PhD graduates – are published in a paper for the journal 'Medical Microbiology and Immunology'. The paper presents significant new findings about the protein properdin – an important part of the immune system. It is a positive regulator in the alternative pathway of complement activation – which means it plays a ...

Wiley advances Knowitall Solutions with new trendfinder application for user-friendly chemometric analysis and additional enhancements to analytical workflows

NIH turns to crowdsourcing to repurpose drugs

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: